Education
About Us
Working with TipRanks
Follow Us
Virbac SA (FR:VIRP)
:VIRP
VIRP Stock Chart & Stats
Day’s Range― - ―
52-Week Range€249.70 - €400.00
Previous CloseN/A
Volume40.00
Average Volume (3M)4.25K
Market Cap
€2.86B
Enterprise Value€1.94B
Total Cash (Recent Filing)€149.63M
Total Debt (Recent Filing)€307.01M
Price to Earnings (P/E)19.7
Beta0.58
Next Earnings
Sep 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 24, 2025Dividend Yield0.43%
Share Statistics
EPS (TTM)6.04
Shares Outstanding8,390,660
10 Day Avg. Volume5,236
30 Day Avg. Volume4,252
Financial Highlights & Ratios
PEG Ratio2.03
Price to Book (P/B)2.29
Price to Sales (P/S)0.00
P/FCF Ratio42.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€390.00Price Target Upside14.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Virbac SA News
Bulls Say, Bears Say
Bulls Say
Regional PerformanceEurope and Latin America are demonstrating solid growth rates of around 8%, contributing positively to Virbac's overall performance.
Sales GrowthVirbac's first-quarter sales figures showed organic growth of 4.9%, aligning with expectations and indicating a promising start to the year.
Bears Say
Earnings GrowthA slowdown in earnings growth is anticipated to continue due to an unfavourable base effect, which may affect investor sentiment.
Regional ChallengesAustralia's market conditions are unfavourable, causing a sharp decline of 15% in the region and negatively impacting Virbac's overall sales.
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
6.39%
Mutual Funds
― Other Institutional Investors
90.60% Public Companies and
Individual Investors
VIRP FAQ
What was Virbac SA’s price range in the past 12 months?
Virbac SA lowest stock price was €249.70 and its highest was €400.00 in the past 12 months.
What is Virbac SA’s market cap?
Virbac SA’s market cap is €2.86B.
When is Virbac SA’s upcoming earnings report date?
Virbac SA’s upcoming earnings report date is Sep 12, 2025 which is in 56 days.
How were Virbac SA’s earnings last quarter?
Virbac SA released its earnings results on Mar 13, 2025. The company reported €6.045 earnings per share for the quarter, beating the consensus estimate of N/A by €6.045.
Is Virbac SA overvalued?
According to Wall Street analysts Virbac SA’s price is currently Undervalued.
Does Virbac SA pay dividends?
Virbac SA pays a Annually dividend of €1.45 which represents an annual dividend yield of 0.43%. See more information on Virbac SA dividends here
What is Virbac SA’s EPS estimate?
Virbac SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Virbac SA have?
Virbac SA has 8,390,660 shares outstanding.
What happened to Virbac SA’s price movement after its last earnings report?
Virbac SA reported an EPS of €6.045 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.328%.
Which hedge fund is a major shareholder of Virbac SA?
Currently, no hedge funds are holding shares in FR:VIRP
Company Description
Virbac SA
Virbac SA is a global pharmaceutical company specializing in the development, manufacture, and commercialization of a broad range of products for animal health. The company operates in various sectors, including companion animals and food-producing animals, providing innovative solutions for the prevention and treatment of diseases across different species. Virbac's core products include vaccines, parasiticides, antibiotics, and dermatological products designed to enhance animal health and well-being.